Manufacturer
BAYER AG
Contents
Moxifloxacin
Indication
Bacterial infections caused by susceptible strains: Community-acquired pneumonia, complicated skin & skin structure infections, intra-abdominal infections including polymicrobial infections eg, abscesses. Tab: Acute sinusitis, acute exacerbations of chronic bronchitis, combination therapy for mild to moderately severe inflammatory pelvic disease.
Instruction
May be taken with or without food.
Drug interaction
Reduced efficacy w/ antacids, anti-retroviral drugs eg, didanosine, Mg-, Al-, Fe- or Zn-containing prep & sucralfate. Reduced bioavailability w/ charcoal.